Advantage of Co-Culture Strategy for Targeted Cancer Treatment and in Vitro Studies
| dc.contributor.author | Ulu, Gizem Tuğçe | |
| dc.contributor.author | Bayram, Nazende Nur | |
| dc.contributor.author | Dinçer İşoğlu, Sevil | |
| dc.contributor.author | Baran, Yusuf | |
| dc.date.accessioned | 2021-11-06T09:49:35Z | |
| dc.date.available | 2021-11-06T09:49:35Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Breast cancer tissues include carcinoma cells and stromal cells, and intra-tumoral stroma that consists of different types of cells. For this point, cell-cell interaction and communication have a potential role in cancer progression. Mono-cell culture is used for cancer treatment approaches. However, cell-cell interaction and communication can not be evaluated on mono-culture cells. So, co-culture models provide low-cost screening to determine cell proliferation for drug application before moving forward to in vivo models. Also, determination of cell morphology in co culture system is critical to understand advantages. | en_US |
| dc.description.sponsorship | Research grants from the Scientific and Technological Research Council of Turkey, Development of Breast Cancer Targeted, More Stable, IV Double-Moiety pHSensitive, Drug-Conjugated, Multifunctional Micelle-Based Nanocarriers and Investigation of Their in vitro Efficiency, Project Number: 116R057. | en_US |
| dc.identifier.doi | 10.1016/j.annonc.2021.08.309 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.08.309 | |
| dc.identifier.uri | https://hdl.handle.net/11147/11482 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Breast cancer | en_US |
| dc.title | Advantage of Co-Culture Strategy for Targeted Cancer Treatment and in Vitro Studies | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Ulu, Gizem Tuğçe | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Molecular Biology and Genetics | en_US |
| gdc.description.endpage | S370 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S370 | en_US |
| gdc.description.volume | 32 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W3203208266 | |
| gdc.identifier.wos | WOS:000700527700032 | |
| gdc.index.type | WoS | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.635068E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 1.9373685E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.16 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 2 | |
| gdc.wos.citedcount | 0 | |
| local.message.claim | 2022-12-08T16:31:15.359+0300 | * |
| local.message.claim | |rp00306 | * |
| local.message.claim | |submit_approve | * |
| local.message.claim | |dc_contributor_author | * |
| local.message.claim | |None | * |
| relation.isAuthorOfPublication.latestForDiscovery | 679729f2-b268-4d85-b686-4c8a63dae23f | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9711dc3e-de1f-44ab-8c8a-00d8a2db8ba5 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S0923753421025382-main.pdf
- Size:
- 90.94 KB
- Format:
- Adobe Portable Document Format
